Semaglutide isn't a single product — it's the active ingredient shared across several different FDA-approved medications, each with its own brand name, dosing, and approved use:
- Ozempic — weekly injection, approved for type 2 diabetes
- Rybelsus — daily oral tablet, approved for type 2 diabetes
- Wegovy (injection) — weekly injection, approved for chronic weight management
- Wegovy (tablet) — daily oral tablet, also approved for chronic weight management
There's currently no generic version of semaglutide on the market — every option above is a brand-name product manufactured by Novo Nordisk. Because the right brand depends heavily on whether you're managing diabetes or pursuing weight loss (and whether you'd rather inject weekly or take a daily pill), this decision is one a licensed provider should walk through with you directly.